[1]
Gül U,Kiliç A,Gönül M,Cakmak SK,Bayis SS, Clinical aspects of epidermodysplasia verruciformis and review of the literature. International journal of dermatology. 2007 Oct
[PubMed PMID: 17910717]
[2]
de Oliveira WR,Festa Neto C,Rady PL,Tyring SK, Clinical aspects of epidermodysplasia verruciformis. Journal of the European Academy of Dermatology and Venereology : JEADV. 2003 Jul
[PubMed PMID: 12834447]
[3]
Tanigaki T,Endo H, A case of epidermodysplasia verruciformis (Lewandowsky-Lutz, 1922) with skin cancer: histopathology of malignant cutaneous changes. Dermatologica. 1984
[PubMed PMID: 6479420]
Level 3 (low-level) evidence
[4]
Patel T,Morrison LK,Rady P,Tyring S, Epidermodysplasia verruciformis and susceptibility to HPV. Disease markers. 2010
[PubMed PMID: 21178278]
[5]
Gewirtzman A,Bartlett B,Tyring S, Epidermodysplasia verruciformis and human papilloma virus. Current opinion in infectious diseases. 2008 Apr
[PubMed PMID: 18317036]
Level 3 (low-level) evidence
[6]
Imahorn E,Yüksel Z,Spoerri I,Gürel G,Imhof C,Saraçoğlu ZN,Koku Aksu AE,Rady PL,Tyring SK,Kempf W,Itin PH,Burger B, Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017 Oct
[PubMed PMID: 28646613]
[7]
Ramoz N,Rueda LA,Bouadjar B,Montoya LS,Orth G,Favre M, Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nature genetics. 2002 Dec
[PubMed PMID: 12426567]
[8]
de Jong SJ,Imahorn E,Itin P,Uitto J,Orth G,Jouanguy E,Casanova JL,Burger B, Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses. Frontiers in microbiology. 2018
[PubMed PMID: 29946305]
[9]
Nindl I,Gottschling M,Stockfleth E, Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Disease markers. 2007
[PubMed PMID: 17627060]
[10]
Adachi A,Kiyono T,Hayashi Y,Ohashi M,Ishibashi M, Detection of human papillomavirus (HPV) type 47 DNA in malignant lesions from epidermodysplasia verruciformis by protocols for precise typing of related HPV DNAs. Journal of clinical microbiology. 1996 Feb
[PubMed PMID: 8789018]
[11]
Yutsudo M,Hakura A, Human papillomavirus type 17 transcripts expressed in skin carcinoma tissue of a patient with epidermodysplasia verruciformis. International journal of cancer. 1987 May 15
[PubMed PMID: 3032809]
[12]
Crequer A,Picard C,Patin E,D'Amico A,Abhyankar A,Munzer M,Debré M,Zhang SY,de Saint-Basile G,Fischer A,Abel L,Orth G,Casanova JL,Jouanguy E, Inherited MST1 deficiency underlies susceptibility to EV-HPV infections. PloS one. 2012
[PubMed PMID: 22952854]
[13]
Crequer A,Troeger A,Patin E,Ma CS,Picard C,Pedergnana V,Fieschi C,Lim A,Abhyankar A,Gineau L,Mueller-Fleckenstein I,Schmidt M,Taieb A,Krueger J,Abel L,Tangye SG,Orth G,Williams DA,Casanova JL,Jouanguy E, Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. The Journal of clinical investigation. 2012 Sep
[PubMed PMID: 22850876]
[14]
Kirchhof MG,Au S, Brazilian waxing and human papillomavirus: a case of acquired epidermodysplasia verruciformis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2015 Feb 3
[PubMed PMID: 25183723]
Level 3 (low-level) evidence
[15]
Gubinelli E,Posteraro P,Cocuroccia B,Girolomoni G, Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin. The Journal of dermatological treatment. 2003 Sep
[PubMed PMID: 14522631]
[16]
Lutzner MA,Blanchet-Bardon C,Orth G, Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. The Journal of investigative dermatology. 1984 Jul
[PubMed PMID: 6330217]
[17]
Partridge ME,Pariser RJ, Ocular and cutaneous squamous cell carcinoma in an African American man with epidermodysplasia verruciformis resulting in blindness and death. Journal of the American Academy of Dermatology. 2003 Nov
[PubMed PMID: 14576647]
[18]
Pereira de Oliveira WR,Carrasco S,Neto CF,Rady P,Tyring SK, Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis. The Journal of dermatology. 2003 Mar
[PubMed PMID: 12692356]
[19]
Lazarczyk M,Cassonnet P,Pons C,Jacob Y,Favre M, The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiology and molecular biology reviews : MMBR. 2009 Jun
[PubMed PMID: 19487731]
[20]
Lazarczyk M,Pons C,Mendoza JA,Cassonnet P,Jacob Y,Favre M, Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. The Journal of experimental medicine. 2008 Jan 21
[PubMed PMID: 18158319]
[21]
Mertz KD,Schmid M,Burger B,Itin P,Palmedo G,Schärer L,Kutzner H,Fernández Figueras MT,Cribier B,Pfaltz M,Kempf W, Detection of Merkel cell polyomavirus in epidermodysplasia-verruciformis-associated skin neoplasms. Dermatology (Basel, Switzerland). 2011 Feb
[PubMed PMID: 21099200]
[22]
Orth G, Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Seminars in immunology. 2006 Dec
[PubMed PMID: 17011789]
[23]
Huang S,Wu JH,Lewis DJ,Rady PL,Tyring SK, A novel approach to the classification of epidermodysplasia verruciformis. International journal of dermatology. 2018 Aug 29
[PubMed PMID: 30156265]
[24]
Przybyszewska J,Zlotogorski A,Ramot Y, Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate. Journal of the American Academy of Dermatology. 2017 Jun
[PubMed PMID: 28196644]
[26]
Anadolu R,Oskay T,Erdem C,Boyvat A,Terzi E,Gürgey E, Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a. Journal of the American Academy of Dermatology. 2001 Aug
[PubMed PMID: 11464195]
[27]
Micali G,Nasca MR,Dall'Oglio F,Musumeci ML, Cimetidine therapy for epidermodysplasia verruciformis. Journal of the American Academy of Dermatology. 2003 Feb
[PubMed PMID: 12582373]
[28]
de Oliveira WR,Neto CF,Rivitti EA, The lack of a clinical effect of cimetidine in the treatment of epidermodysplasia verruciformis. Journal of the American Academy of Dermatology. 2004 Jun
[PubMed PMID: 15153919]
[29]
Rajabi MT,Ghasemi H,Safizadeh M,Jamshidi S,Asadi-Amoli F,Abrishami Y,Oestreicher JH, Conjunctival squamous cell carcinoma with intraocular invasion after radiotherapy in epidermodysplasia verruciformis. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2014 Apr
[PubMed PMID: 24767238]
[30]
Vohra S,Sharma NL,Shanker V,Mahajan VK,Jindal N, Autosomal dominant epidermodysplasia verruciformis: a clinicotherapeutic experience in two cases. Indian journal of dermatology, venereology and leprology. 2010 Sep-Oct
[PubMed PMID: 20826999]
Level 3 (low-level) evidence